Jakafi (Ruxolitinib)

Ruxolitinib · Incyte

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Jakafi (Ruxolitinib), covering 2025-04-30 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders [Phase 2]